Cholera Toxins

Cholera Toxins-1

Keya Chaudhuri • S.N. Chatterjee 2009 To start with, we feel that we should explain why the book has been entitled Cholera Toxins. In fact, the enterotoxin secreted by Vibrio cholerae, which is primarily responsible for causation of the disease, is conventionally known as or referred to as cholera toxin, or CT. By using the word “toxins” (in […]

Continue reading →

Checkpoint Controls and Targets in Cancer Therapy

Checkpoint Controls and Targets in Cancer Therapy-1

Edited by Zahid H. Siddik 2009 Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of cancer. This loss can occur through aberration in any one single component of the many signal transduction pathways that orchestrate checkpoint regulation, and results in either a failure to […]

Continue reading →

Cell and Tissue Reaction Engineering

Cell and Tissue Reaction Engineering-1

Regine Eibl • Dieter Eibl • Ralf Pörtner Gerardo Catapano • Peter Czermak 2009 Principles and Practice The completion of the Human Genome Project and the rapid progress in cell biology and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily […]

Continue reading →

Carotenoids Volume 5

Carotenoids-1

Edited by G. Britton S. Liaaen-Jensen H. Pfander 2009 More than twenty years after the idea of this Carotenoids book series was first discussed, we finally reach the end of the project with Volume 5, which covers the functions and actions of carotenoids in human nutrition and health. In 1971, in Isler’s book Carotenoids, functions of carotenoids and […]

Continue reading →

Erythropoietins, Erythropoietic Factors, and Erythropoiesis

Erythropoietins, Erythropoietic Factors, and Erythropoiesis-1

Edited by Steven G. Elliott, MaryAnn Foote, and Graham Molineux 2009 Molecular, Cellular, Preclinical, and Clinical Biology Cloning of the erythropoietin (EPO) gene was accomplished in the 1980s, allowing a breakthrough in the treatment of anemia. Now more than 2 decades later, important new understandings on erythropoiesis and EPO are revealed as a consequence of continued research in […]

Continue reading →